Clinical Trials Logo

Clinical Trial Summary

Low back pain, associated with intrinsic disorders of the spine, is a very frequent clinical condition that is accompanied by high morbidity with effects both on psychosocial aspects, and health care system. It occurs in approximately 80% of the population throughout their lives. Most low back pain is associated with intervertebral disc degeneration (IDD) associated with neuroinflammation and pain. In this context, the study of sphingolipid metabolism can play an important role in the identification of new molecules responsible for the degenerative process. Sphingolipids, in fact, are a class of molecules that are implicated in multiple signal pathways, such as proliferation, degradation of the extracellular matrix, inflammatory state, apoptosis and migration. In particular, sphingosine-1-phosphate (S1P), an intermediate of sphingolipid metabolism, acts as a pro-inflammatory mediator, predominantly in the extracellular environment, regulating important cellular properties related to inflammatory potential and pain. The objective of this study is to characterize the degenerative process in cells isolated from degenerated human intervertebral discs from both at cellular and molecular levels in order to identify new targets implicated in degenerative processes, including sphingolipid signaling pathway.


Clinical Trial Description

Low back pain (LBP) is a serious public health problem and has been identified as the most widespread cause of disability worldwide by the 2013 Global Burden of Disease Study. It is estimated that in the Western world the annual incidence of acute low back pain is 5% in adults and that the lifetime prevalence is 80%. Although different anatomical structures can be implicated in the generation of LBP, in many cases this is associated with the degeneration of the intervertebral disc (IVD). IVD degeneration (IDD) represents a chronic age-related process, characterized by a progressive reduction in the content of proteoglycans and water in the nucleus pulposus (NP) with the subsequent loss of the ability of the disc to respond to compressive forces with the possible appearance of instability. Furthermore, this degenerative process is accompanied by the development of a highly inflammatory microenvironment which contributes to exacerbating the degenerative process, leading to the progressive structural failure of the disc itself and in most cases, to pain. From these premises, arises the need to better investigate all the cell-mediated mechanisms underlying IDD, to identify and develop new therapies aimed at recovering the IVD and reducing pain. In this context, sphingolipids, a class of molecules responsible for multiple signal pathways such as proliferation, migration, apoptosis and angiogenesis, appear to play a key role in exacerbating the inflammatory process and degradation of the extracellular matrix in conditions of IDD. Sphingosine-1-phosphate (S1P) is an intermediate of sphingolipid metabolism, formed from sphingosine through the action of sphingosine kinases (SphK1, SphK2). Increasing evidence suggests that S1P acts as a pro-inflammatory signal, predominantly in the extracellular environment, regulating important cellular properties correlated with the inflammatory potential on chondrocyte-like cells. It has been reported that an alteration in the production and secretion of these molecules is capable of increasing the inflammatory and degenerative condition in various pathologies related to neuroinflammation and pain. The aim of the project is to define new disease biomarkers and characterize the degenerative process in cells isolated from degenerated human intervertebral discs from both at cellular and molecular levels in order to identify new targets implicated in degenerative processes, including sphingolipid signaling pathway. Secondary objective is the analysis of the effectiveness of the modulation of sphingolipid metabolism and the in vitro testing of molecules with therapeutic potential. A greater understanding of the events implicated in the pathogenesis of IDD both at macroscopic and microscopic levels, is of fundamental importance for the development of new diagnostic tools, to be combined with current therapeutic strategies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06349226
Study type Observational
Source Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Contact Giovanni Marfia, MD, PhD
Phone 0255034268
Email giovanni.marfia@policlinico.mi.it
Status Recruiting
Phase
Start date May 22, 2018
Completion date May 21, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06342765 - Safety and Performance of the SpineVision Posterior Fixation Systems in Thoracolumbar Spinal Treatment
Recruiting NCT03076658 - Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04702126 - Smoking Effect on Lumbar Intervertebral Disc Degeneration
Completed NCT02586116 - Comparison of nanOss Cervical IBF System to C-Plus PEEK IBF Device With Autograft N/A
Recruiting NCT02400762 - Prospective Study of Safety and Efficacy of InQu® Bone Graft Extender in Lumbar Interbody Fusion Surgery N/A
Recruiting NCT04600544 - Russian Disc Degeneration Study
Not yet recruiting NCT04134910 - The Role of Disc Nutrition in the Etiology and Clinical Treatment of Disc Degeneration N/A
Withdrawn NCT03908203 - Minimally Invasive Surgery Techniques for One-level Degenerative Lumbar Deformities Correction N/A
Recruiting NCT01989481 - Predicting the Outcome of Total Knee Arthroplasty and Spinal Surgeon N/A
Active, not recruiting NCT04759105 - Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD Phase 2
Recruiting NCT03105167 - Cortical Bone Trajectory Screws vs. Traditional Pedicle Screws Fixation N/A
Enrolling by invitation NCT05110833 - Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
Recruiting NCT05066334 - Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD Phase 2
Terminated NCT02381067 - A Prospective Study of NuCel® in Cervical Spine Fusion N/A
Completed NCT01944345 - Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device N/A
Recruiting NCT05997121 - Safety and Performance of the Hexanium TLIF System in the Treatment of Degenerative Disc Disease
Active, not recruiting NCT06155409 - Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease
Recruiting NCT05648474 - Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure
Enrolling by invitation NCT05098431 - Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery N/A